BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3083783)

  • 1. [Factors controlling tumor promotion induced by TPA].
    Kato R; Yamamoto S; Nakadate T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):782-9. PubMed ID: 3083783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Pong RC; Erickson D
    Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Gan; 1984 Mar; 75(3):214-22. PubMed ID: 6427052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lipoxygenase and cyclooxygenase inhibitors on the induction of ornithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate and isoproterenol in mouse tissues in vivo.
    Uzumaki H; Yamamoto S; Kato R
    Carcinogenesis; 1986 Feb; 7(2):289-94. PubMed ID: 3081271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition.
    Kato R; Nakadate T; Yamamoto S; Sugimura T
    Carcinogenesis; 1983 Oct; 4(10):1301-5. PubMed ID: 6413085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects.
    Aizu E; Nakadate T; Yamamoto S; Kato R
    Carcinogenesis; 1986 Nov; 7(11):1809-12. PubMed ID: 3094975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and tumor promotion by N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) in mouse skin.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Pharmacology; 1986; 32(3):167-75. PubMed ID: 3083437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK
    Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and epidermal ornithine decarboxylase activity in mouse skin by palmitoylcarnitine.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Cancer Res; 1986 Apr; 46(4 Pt 1):1589-93. PubMed ID: 3081251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potent anti-tumor-promoting agent isoliquiritigenin.
    Yamamoto S; Aizu E; Jiang H; Nakadate T; Kiyoto I; Wang JC; Kato R
    Carcinogenesis; 1991 Feb; 12(2):317-23. PubMed ID: 1899810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase A2 inhibitor.
    Nakadate T; Yamamoto S; Iseki H; Sonoda S; Takemura S; Ura A; Hosoda Y; Kato R
    Gan; 1982 Dec; 73(6):841-3. PubMed ID: 6819174
    [No Abstract]   [Full Text] [Related]  

  • 13. Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-caused ornithine decarboxylase induction in mouse epidermis.
    Aizu E; Yamamoto S; Nakadate T; Kiyoto I; Kato R
    Carcinogenesis; 1988 Feb; 9(2):309-13. PubMed ID: 3338115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
    Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
    Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
    Fischer SM; Jasheway DW; Klann RC; Butler AP; Patrick KE; Baldwin JK; Cameron GS
    Cancer Res; 1989 Dec; 49(23):6693-9. PubMed ID: 2819717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism.
    Fischer SM; Mills GD; Slaga TJ
    Carcinogenesis; 1982; 3(11):1243-5. PubMed ID: 7151243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
    Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
    Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of skin tumor promotion by retinoic acid and its metabolite 5,6-epoxyretinoic acid.
    Verma AK; Slaga TJ; Wertz PW; Mueller GC; Boutwell RK
    Cancer Res; 1980 Jul; 40(7):2367-71. PubMed ID: 7388798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.